Showing results (81-90 of 341) with videos related to
Sort By:
Pageof 35
Cardiovascular Diabetology|April 26, 2008
Effect of the addition of rosiglitazone to metformin or sulfonylureas versus metformin/sulfonylurea combination therapy on ambulatory blood pressure in people with type 2 diabetes: a randomized controlled trial (the RECORD study)Michel Komajda, Paula Curtis, Markolf Hanefeld, et al.Diabetes Research and Clinical Practice|May 22, 2024
Impact of empagliflozin on first and recurrent events leading to or prolonging hospitalisation in the EMPA-REG OUTCOME trialSilvio E Inzucchi, Christoph Wanner, David Fitchett, et al.Journal of the American College of Cardiology|February 15, 2015
Duration of dual antiplatelet therapy after drug-eluting stent implantation: a systematic review and meta-analysis of randomized controlled trialsGennaro Giustino, Usman Baber, Samantha Sartori, et al.JACC. Heart Failure|November 3, 2022
Steroidal MRA Across the Spectrum of Renal Function: A Pooled Analysis of RCTsJoão Pedro Ferreira, Bertram Pitt, John J V McMurray, et al.Annals of Internal Medicine|October 4, 2017
Predicting 30-Day Mortality for Patients With Acute Heart Failure in the Emergency Department: A Cohort StudyÒscar Miró, Xavier Rossello, Víctor Gil, et al.The New England Journal of Medicine|June 7, 2007
Rosiglitazone evaluated for cardiovascular outcomes--an interim analysisPhilip D Home, Stuart J Pocock, Henning Beck-Nielsen, et al.The New England Journal of Medicine|November 25, 2006
Bivalirudin for patients with acute coronary syndromesGregg W Stone, Brent T McLaurin, David A Cox, et al.International Journal of Cardiology|August 21, 2007
Costs of an early intervention versus a conservative strategy in acute coronary syndromeDavid M Epstein, Mark J Sculpher, Tim C Clayton, et al.JAMA|February 15, 2007
Routine upstream initiation vs deferred selective use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: the ACUITY Timing trialGregg W Stone, Michel E Bertrand, Jeffrey W Moses, et al.European Journal of Heart Failure|November 30, 2020
Design of a prospective patient-level pooled analysis of two parallel trials of empagliflozin in patients with established heart failureMilton Packer, Javed Butler, Gerasimos Filippatos, et al.Pageof 35